How should the work‑up and management of a 70‑year‑old patient with sudden urges to pass gas (and occasional stool) and urinary urgency every 1–2 hours be approached?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of a 70-Year-Old with Urinary Urgency and Bowel Urgency

Your 70-year-old patient presenting with both urinary urgency every 1-2 hours and sudden urges to pass gas/stool represents a dual pelvic floor dysfunction that requires simultaneous evaluation and treatment of both overactive bladder (OAB) and bowel symptoms, starting with behavioral interventions before considering pharmacotherapy.

Understanding the Connection

The coexistence of urinary and bowel urgency in your patient is not coincidental. Recent evidence demonstrates that fecal urgency is strongly associated with urge urinary incontinence, with 40.3% of patients with fecal urgency also experiencing urinary urgency symptoms 1. This suggests a shared pathophysiology involving altered pelvic floor biomechanics and sensory dysfunction. In elderly patients specifically, comorbidity is a significant predictor of incident urgency urinary incontinence (OR=5.54) 2.

Initial Diagnostic Approach

For this 70-year-old, you need to:

  • Obtain a voiding diary documenting frequency, urgency episodes, and any incontinence over 3 days
  • Perform urinalysis to exclude urinary tract infection 3
  • Measure post-void residual to rule out retention or overflow incontinence
  • Review current medications for drugs that may worsen urgency (diuretics, anticholinergics, sedatives)
  • Assess for comorbidities: diabetes, neurological conditions, cognitive impairment, functional limitations 2
  • Physical examination: abdominal exam, rectal exam, assessment for lower extremity edema 4

Important caveat: Urodynamic studies are NOT indicated initially for uncomplicated OAB 4, 5. Reserve these for refractory cases or when considering invasive treatments.

First-Line Treatment: Behavioral Therapies

You must start with behavioral interventions as first-line therapy 3, 4. These are strongly recommended (Grade B evidence) and have excellent safety profiles particularly important in elderly patients:

Bladder-Specific Interventions:

  • Bladder training: Scheduled voiding with progressive interval extension (start at current interval, extend by 15-30 minutes weekly) 3
  • Fluid management: Reduce total intake by 25% if excessive, limit fluids 2-3 hours before bedtime 4
  • Caffeine reduction: Eliminate or significantly reduce caffeine intake 4
  • Urge suppression techniques: Teach pelvic floor muscle contraction when urgency occurs to inhibit detrusor contractions

Bowel-Specific Interventions:

  • Regular bowel regimen: Scheduled toileting after meals to utilize gastrocolic reflex
  • Address constipation: This is a risk factor for urinary incontinence 3
  • Dietary modifications: Identify and eliminate trigger foods

When Behavioral Therapy Fails: Pharmacologic Treatment

If bladder training is unsuccessful after 4-8 weeks, add antimuscarinic medication 3. This is a strong recommendation with high-quality evidence (Grade A).

Medication Selection for a 70-Year-Old:

The choice should prioritize tolerability, adverse effect profile, and cognitive safety 3. For elderly patients, this is critical:

Best initial choices:

  • Darifenacin or tolterodine: These have discontinuation rates due to adverse effects similar to placebo 3
  • Solifenacin: Associated with the lowest risk for discontinuation due to adverse effects among antimuscarinics 3

Avoid as first choice:

  • Oxybutynin: Highest discontinuation rate (NNTH=16) and more dry mouth/insomnia 3

Dosing strategy: Start at the lowest dose and titrate based on response and tolerability. Consider dose modification before switching agents 3, 6.

Critical Safety Considerations in the Elderly:

  • Cognitive effects: Antimuscarinics can impair cognition in elderly patients 7, 8. Fesoterodine has shown low/no risk of cognitive impairment 9
  • Post-void residual monitoring: Check PVR after starting medication; use caution if PVR 250-300 mL 4
  • Drug interactions: Review all medications for potential interactions
  • Constipation: Antimuscarinics worsen constipation, which may exacerbate bowel urgency symptoms 3

Addressing the Bowel Component

The bowel urgency requires parallel management:

  • Rule out infectious causes (stool studies if diarrhea present)
  • Consider anorectal manometry if symptoms persist, as patients with fecal urgency show altered rectal biomechanics 1
  • Behavioral modifications: dietary fiber adjustment, scheduled defecation
  • Consider referral to gastroenterology if refractory

Common Pitfalls to Avoid:

  1. Don't assume symptoms are "normal aging": 75% of elderly women have UI, but it's treatable 3
  2. Don't start with medications: Behavioral therapy is equally or more effective than pharmacotherapy with fewer adverse effects 4
  3. Don't ignore the bowel symptoms: The dual presentation suggests shared pathophysiology requiring integrated treatment 1
  4. Don't overlook functional status: IADL disability predicts incident urgency UI (OR=4.18) 2
  5. Don't forget incontinence management: Discuss pads, barrier creams, and protective garments to maintain quality of life during treatment 5

Treatment Goals and Follow-Up

Success is defined as ≥50% reduction in urgency episodes 3. Follow up at:

  • 2-4 weeks: Assess behavioral therapy adherence and symptom improvement
  • 4-8 weeks: If adding medication, evaluate efficacy and adverse effects
  • 3 months: Reassess with voiding diary and consider dose adjustment or alternative agent

If symptoms remain refractory after optimized behavioral and pharmacologic therapy, consider referral to urology/urogynecology for evaluation of third-line therapies (botulinum toxin, neuromodulation) 4, 5.

Related Questions

What is the appropriate management for a 43‑year‑old female with new‑onset urinary urgency and frequency over the past day and a normal urinalysis?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
Can hepatitis A virus be transmitted through close personal contact?
If the meta‑analysis is limited to colon cancer, can we further restrict it to left‑sided colon tumors to focus on higher anastomotic leak rates?
What is the appropriate evaluation and management for a patient who experiences simultaneous urges to pass flatus (and occasionally stool) and to urinate every 1–2 hours, without fever, bloating, or abdominal distension?
What is an appropriate substitute for ethosuximide?
Can I prescribe ofloxacin and ornidazole for an upper respiratory tract infection?
Is it feasible to conduct a network meta‑analysis comparing oral ciprofloxacin plus metronidazole plus intravenous prophylactic antibiotics with mechanical bowel preparation versus oral neomycin plus metronidazole plus intravenous prophylactic antibiotics with mechanical bowel preparation on anastomotic leak and surgical‑site infection rates in patients with left‑sided colonic adenocarcinoma undergoing primary surgery?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.